文献速递银屑病与炎症性皮肤病皮肤肿瘤湿疹皮炎与荨麻疹

丝聚蛋白功能丧失突变、特应性皮炎与光化性角化病风险

Filaggrin loss-of-function mutations, atopic dermatitis and risk of actinic keratosis: results from two cross-sectional studies.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2017-03-06

两项横断面研究显示,纯合FLG突变者光化性角化病(AK)患病率(0.8%)高于对照(0.2%),杂合突变者更低;医院登记数据中特应性皮炎(AD)患者AK风险高于银屑病对照(调整OR 1.46,95%CI 1.12-1.90),而鱼鳞病与AD间无差异。

要点

  • 纯合FLG突变者AK患病率高于一般人群对照,杂合突变者反而更低。
  • AD患者AK风险高于银屑病对照(调整OR 1.46,95%CI 1.12-1.90)。
  • 鱼鳞病与AD患者之间AK风险无差异。

核心结论

  • 纯合而非杂合FLG突变个体及AD患者(相较银屑病)对AK易感性增加。
  • 表皮丝聚蛋白减少或缺失是否促成AK易感性尚不明确,需进一步研究。

研究设计与样本

  • 第一项为横断面研究,比较AK患者与一般人群对照的FLG突变状态。
  • 第二项基于丹麦全国登记数据,比较鱼鳞病、AD和银屑病患者的AK风险。

主要发现

  • AK组纯合FLG突变患病率0.8%(n=4),高于对照组0.2%(n=18)。
  • AK组杂合FLG突变患病率低于对照组。
  • 医院登记数据中AD患者AK风险高于银屑病对照(调整OR 1.46;95%CI 1.12-1.90)。
  • 鱼鳞病与AD患者之间AK风险无差异。

关键数值与推荐

  • 纯合FLG突变患病率:AK组0.8%(n=4) vs 对照组0.2%(n=18)。
  • AD vs 银屑病对照的AK风险:调整OR 1.46(95%CI 1.12-1.90)。

临床怎么用

  • 对纯合FLG突变或AD患者应关注AK筛查与防晒指导。
  • AD患者AK风险高于银屑病患者,鉴别诊断时需考虑。

局限性

  • 纯合突变携带者样本量小(AK组n=4,对照组n=18)。
  • 表皮丝聚蛋白减少或缺失与AK易感性的机制尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Common loss-of-function mutations in filaggrin gene (FLG) represent a strong genetic risk factor for atopic dermatitis (AD). Homozygous mutation carriers typically display ichthyosis vulgaris (IV) and many have concomitant AD. Previously, homozygous, but not heterozygous, filaggrin gene mutations have been associated with squamous cell carcinomas. OBJECTIVE: The first objective was to examine the association between FLG mutations and actinic keratosis (AK). The second objective was to investigate the occurrence of AK in patients with IV and AD, respectively. METHODS: FLG mutation status in patients with AK was compared with controls from the general population. Furthermore, based on nationwide data from Danish registers, we compared the risk of AK in patients with IV, AD and psoriasis, respectively. RESULTS: The prevalence of homozygous FLG mutations was significantly higher in the AK group (n = 4, 0.8%) in comparison with the control group (n = 18, 0.2%), whereas the prevalence of heterozygous FLG mutations was lower. In hospital registry data, patients with AD exhibited an increased risk of AK than did psoriasis controls (adjusted OR 1.46; [95% CI 1.12-1.90]), whereas no difference in risk was observed between patients with IV and AD. CONCLUSIONS: This study indicates an increased susceptibility to AK in individuals with homozygous, but not heterozygous, FLG mutations and in patients with AD compared to psoriasis. Whether a reduction or absence of epidermal filaggrin could contribute to the susceptibility to AK in patients with IV and AD is unknown and additional research is needed to further explore this relationship.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Andersen YMF, Egeberg A, Balslev E, et al. Filaggrin loss-of-function mutations, atopic dermatitis and risk of actinic keratosis: results from two cross-sectional studies. J Eur Acad Dermatol Venereol. 2017. PMID: 28213896. doi:10.1111/jdv.14172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。